Yang XN

No ORCID on file · 2 papers in corpus

2022

P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough.

Computational and structural biotechnology journal ·doi:10.1016/j.csbj.2022.03.030

Gefapixant/AF-219, a selective inhibitor of the P2X3 receptor, is the first new drug other than dextromethorphan to be approved for the treatment of refractory chronic cough (RCC) in nearly 60 years. To date, seven P2X subtypes (P2X1-7) act…

2016

Right upper lobectomy performed as dividing posterior ascending artery-bronchus-pulmonary vessels is alternative to primary indolent scar carcinomas.

Journal of thoracic disease ·doi:10.21037/jtd.2016.04.09

We describe a case of pulmonary indolent malignancy requiring a strategic surgery and introduce an alternative technique of right upper lobectomy via video-assisted thoracic surgery (VATS) for primary lung cancer patients. A 42-year-old mal…